Effects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomes

International Journal of Pharmaceutics

Volumn 483, Issue 1-2, 2015, Pages 142-150

  Hong, Soon Seok ^a   Kim, So Hee ^b   Lim, Soo Jeong ^a  

^a Sejong University   (South Korea)

^b Ajou University   (South Korea)

Author keywords

Fluidity; Hydrophobic drug; Liposome; Multilamellar vesicle; Triglyceride

Indexed keywords

CHOLESTEROL; DILAUROYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DOCETAXEL; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; PACLITAXEL; PHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENT; LIPOSOME; TRIACYLGLYCEROL;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FREEZE DRYING; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; LIPID SOLUBILITY; LIPOSOME MEMBRANE; MEMBRANE FLUIDITY; PARTICLE SIZE; PHASE TRANSITION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; SOLUBILITY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; PACLITAXEL; PHASE TRANSITION; PHOSPHATIDYLCHOLINES; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 84923107528     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.02.013     Document Type: Article

References (37)

1. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug. Deliv. Rev. 65 2013 36 48
2. C. Bernsdorff, R. Reszka, and R. Winter Interaction of the anticancer agent Taxol (paclitaxel) with phospholipid bilayers J. Biomed. Mater. Res. 46 1999 141 149
3. U. Bhardwaj, and D.J. Burgess Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone Int. J. Pharm. 388 2010 181 189
4. A. Bhatia, R. Kumar, and O.P. Katare Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation J. Pharm. Pharm. Sci. 7 2004 252 259
5. R.B. Campbell, S.V. Balasubramanian, and R.M. Straubinger Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes J. Pharm. Sci. 90 2001 1091 1105
6. H.I. Chang, and M.K. Yeh Clinical development of liposome-based drugs: formulation characterization and therapeutic efficacy Int. J. Nanomed. 7 2012 49 60
7. H. Choudhury, B. Gorain, S. Karmakar, and T.K. Pal Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel J. Chromatogr. Sci. 52 2014 68 74
8. P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio, and L. Cattel Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes J. Control. Release 63 2000 19 30
9. A. Deniz, A. Sade, F. Severcan, D. Keskin, A. Tezcaner, and S. Banerjee Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics Biosci. Rep. 30 2010 365 373
10. A. Goundalkar, and M. Mezei Chemical modification of triamcinolone acetonide to improve liposomal encapsulation J. Pharm. Sci. 73 1984 834 835
11. M. Heney, M. Alipour, D. Vergidis, A. Omri, C. Mugabe, J. Th'ng, and Z. Suntres Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells Can. J. Physiol. Pharmacol. 88 2010 1172 1180
12. S.-S. Hong, and S.-J. Lim Laboratory scale production of injectable liposomes by using cell disruptor to avoid the probe sonication process J. Pharm. Invest. 2014 1 6 http://link.springer.com/article/10.1007/s40005-014-0146-z#
13. M.L. Immordino, P. Brusa, S. Arpicco, B. Stella, F. Dosio, and L. Cattel Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel J. Control. Release 91 2003 417 429
14. D.I. Kang, S. Lee, J.T. Lee, B.J. Sung, J.Y. Yoon, J.K. Kim, J. Chung, and S.J. Lim Preparation and in vitro evaluation of anti-VCAM-1-Fab'-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib J. Microencapsul. 28 2011 220 227
15. H.K. Kang, E. Lee, H. Pyo, and S.J. Lim Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells Mol. Cancer Ther. 4 2005 1358 1363
16. S.N. Kang, S.-S. Hong, S.-Y. Kim, H. Oh, M.-K. Lee, and S.-J. Lim Enhancement of liposomal stability and cellular drug uptake by incorporating tributyrin into celecoxib-loaded liposomes AJPS 8 2013 128 133
17. S. Koudelka, P. Turanek-Knotigova, J. Masek, Z. Korvasova, M. Skrabalova, J. Plockova, E. Bartheldyova, and J. Turanek Liposomes with high encapsulation capacity for paclitaxel: preparation, characterisation and in vivo anticancer effect J. Pharm. Sci. 99 2010 2309 2319
18. S. Koudelka, and J. Turanek Liposomal paclitaxel formulations J. Control. Release 163 2012 322 334
19. E.H. Lee, S.S. Hong, S.H. Kim, M.K. Lee, J.S. Lim, and S.J. Lim Computed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxel Pharm. Res. 31 2014 2022 2034
20. J.Y. Lehtonen, and P.K. Kinnunen Poly(ethylene glycol)-induced and temperature-dependent phase separation in fluid binary phospholipid membranes Biophys. J. 68 1995 525 535
21. S.J. Lim, E. Lee, E.H. Lee, S.Y. Kim, J.H. Cha, H. Choi, W. Park, H.K. Choi, S.H. Ko, and S.H. Kim Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis Oncol. Rep. 27 2012 2023 2030
22. P. Mattjus, and J.P. Slotte Does cholesterol discriminate between sphingomyelin and phosphatidylcholine in mixed monolayers containing both phospholipids? Chem. Phys. Lipids 81 1996 69 80
23. T.P. McMullen, R.N. Lewis, and R.N. McElhaney Differential scanning calorimetric study of the effect of cholesterol on the thermotropic phase behavior of a homologous series of linear saturated phosphatidylcholines Biochemistry 32 1993 516 522
24. D. Needham, and E. Evans Structure and mechanical properties of giant lipid (DMPC) vesicle bilayers from 20 degrees C below to 10 degrees C above the liquid crystal-crystalline phase transition at 24 degrees C Biochemistry 27 1988 8261 8269
25. M.H. Park, C.G. Keum, J.Y. Song, D. Kim, and C.W. Cho A novel aqueous parenteral formulation of docetaxel using prodrugs Int. J. Pharm. 462 2014 1 7
26. J. Parmentier, M.M. Becker, U. Heintz, and G. Fricker Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids Int. J. Pharm. 405 2011 210 217
27. N.M. Payton, M.F. Wempe, J.L. Betker, T.W. Randolph, and T.J. Anchordoquy Lyophilization of a triply unsaturated phospholipid: effects of trace metal contaminants Eur. J. Pharm. Biopharm. 85 2013 306 313
28. D. Qu, H. Lin, N. Zhang, J. Xue, and C. Zhang In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery Carbohydr. Polym. 92 2013 545 554
29. J. Senior, and G. Gregoriadis Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components Life. Sci. 30 1982 2123 2136
30. A.P. Serro, R. Galante, A. Kozica, P. Paradiso, A.M. da Silva, K.V. Luzyanin, A.C. Fernandes, and B. Saramago Effect of tetracaine on DMPC and DMPC+ cholesterol biomembrane models: liposomes and monolayers Colloid Surf. B. Biointerfaces 116 2014 63 71
31. A. Sharma, and R.M. Straubinger Novel taxol formulations: preparation and characterization of taxol-containing liposomes Pharm. Res. 11 1994 889 896
32. A.S. Ulrich Biophysical aspects of using liposomes as delivery vehicles Biosci. Rep. 22 2002 129 150
33. R. van der Meel, M.H. Fens, P. Vader, W.W. van Solinge, O. Eniola-Adefeso, and R.M. Schiffelers Extracellular vesicles as drug delivery systems: lessons from the liposome field J. Control. Release 195c 2014 72 85
34. E.C. van Winden, and D.J. Crommelin Short term stability of freeze-dried, lyoprotected liposomes J. Control. Release 58 1999 69 86
35. T. Yang, F.D. Cui, M.K. Choi, J.W. Cho, S.J. Chung, C.K. Shim, and D.D. Kim Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation Int. J. Pharm. 338 2007 317 326
36. X. Yang, X. Zhao, M.A. Phelps, L. Piao, D.M. Rozewski, Q. Liu, L.J. Lee, G. Marcucci, M.R. Grever, J.C. Byrd, J.T. Dalton, and R.J. Lee A novel liposomal formulation of flavopiridol Int. J. Pharm. 365 2009 170 174
37. J.A. Zhang, G. Anyarambhatla, L. Ma, S. Ugwu, T. Xuan, T. Sardone, and I. Ahmad Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation Eur. J. Pharm. Biopharm. 59 2005 177 187